Prenatal Testing & Newborn Screening Market Report 2026

Prenatal Testing & Newborn Screening Market Overview

• Prenatal Testing & Newborn Screening market size has reached to $6.98 billion in 2025 • Expected to grow to $12.22 billion in 2030 at a compound annual growth rate (CAGR) of 11.8% • Growth Driver: High Prevalence Of Genetic Diseases In Infants Fuels The Growth Of Prenatal Testing And Newborn Screening Market • Market Trend: Major Companies Focus On Innovative Newborn Screening Devices For Early Detection And Accessible Healthcare • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Prenatal Testing & Newborn Screening Market?

Prenatal testing and newborn screening refer to the combined medical practices aimed at assessing the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing includes various assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, allowing for early intervention and treatment to improve health outcomes for infants. The main diagnostic types of prenatal testing and newborn screening are non-invasive and invasive. Invasive diagnostic testing necessitates puncturing the skin or invading the body. A few examples include blood testing, biopsies, and colonoscopies. The different technologies include screening technology, diagnostic technology and is used in various sectors such as hospitals, and diagnostic centres.

What Is The Prenatal Testing & Newborn Screening Market Growth Forecast?

The prenatal testing & newborn screening market size is expected to see rapid growth in the next few years. It will grow to $12.22 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing expansion of national screening mandates, rising adoption of digital diagnostic platforms, growing investments in maternal and child healthcare, increasing focus on preventive healthcare models, expanding use of ai-assisted diagnostics. Major trends in the forecast period include increasing adoption of integrated prenatal and newborn screening programs, rising use of combined screening and diagnostic technologies, growing implementation of early intervention protocols, expansion of automated screening workflows, enhanced focus on population-wide screening.

Global Prenatal Testing & Newborn Screening Market Segmentation

1) By Diagnostic Type: Non-Invasive, Invasive 2) By Technology: Screening Technology, Diagnostic Technology 3) By End User: Hospitals, Diagnostic centers Subsegments: 1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening 2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

What Are The Drivers Of The Prenatal Testing & Newborn Screening Market?

The high prevalence of genetic diseases in infants contributed to the growth of the prenatal testing & newborn screening market. According to the World Health Organization, genetic disease includes diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. The sickle cell anemia is one of the genetic diseases that affects millions throughout the world, and the disease is particularly common among people whose ancestors are from Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, in February 2023, according to the Rady Children's Institute for Genomic Medicine, a US-based research institute, in a study conducted at Rady Children’s Hospital, 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. The high prevalence of genetic diseases in infants boosted the demand for growth of the prenatal testing and newborn screening market. The growth in the birth rate is expected to propel the prenatal testing and newborn screening market growth. The birth rate, also known as natality, is defined as the total number of live human births per 1,000 population for a specific period, divided by the length of that period in years. Prenatal testing helps assess the health of the fetus before birth, while newborn screening tests detect certain medical conditions in newborns shortly after birth, aiding in early intervention if needed. For instance, in April 2024, according to a report published by the Centers for Disease Control and Prevention, a US-based government agency, the cesarean delivery rate rose for the fourth consecutive year in 2023, reaching 32.4%, while the rate of low-risk cesarean deliveries climbed to 26.6%. Therefore, growth in the birth rate drives the growth of the prenatal testing and newborn screening market.

Key Players In The Global Prenatal Testing & Newborn Screening Market

Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

Global Prenatal Testing & Newborn Screening Market Trends and Insights

Major companies operating in the prenatal testing & newborn screening market focus on developing newborn screening devices to enhance early detection of genetic, metabolic, and other health conditions, enabling timely interventions and improved health outcomes for newborns. Newborn screening point-of-care device is designed to provide faster, more accessible, and cost-effective screening for newborns, accommodating the seven standard newborn screening tests conducted globally. For instance, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is designed to be low-cost, estimated to be about one-fifth the price of existing solutions, which often range from ₹50 lakhs to ₹7 crores.: By bringing testing directly to healthcare providers, MyNeoShield aims to improve access to critical health services for newborns, particularly in underserved regions.

Regional Outlook

North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prenatal Testing & Newborn Screening Market?

The prenatal testing & newborn screening market includes revenues earned by entities by providing blood test services, hearing test services, CCHD screening tests, and non-invasive tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Prenatal Testing & Newborn Screening Market Report 2026?

The prenatal testing & newborn screening market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal testing & newborn screening industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.